Grand Rounds by OncoDaily: AI in Oncology Edition

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

The Questions Women Are Afraid to Ask During Breast Radiotherapy and Why That Silence Matters?

Lung Cancer Europe Board for 2026

Oncology News, Insights, Stories by OncoDaily

OncoDiscovery
OncoDaily Pulse

OncoDiscovery Award - A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World

ASCO 2025-OncoDaily
Career Updates

ASCO Announces 2026–2027 Leadership Development Program Cohort

OncoDaily at ASCO 2026
OncoDaily Pulse

OncoDaily at ASCO 2026

Talha Badar: Adverse Risk AML and the Critical Role of Transplantation

Shane Jacobson: Ensuring No Cancer Patient Faces the Burden of Housing During Treatment

Remembering Martine Van Glabbeke: EORTC Leader in Cancer Trial Design

Top 10 Breast Cancer Abstracts To Watch At ESMO Breast Cancer 2026

Tania Small Receives ACS Humanitarian Award 2026

Dario Trapani: Advancing Oncology Innovation Under Persistent Constraints

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology - Key Takeaways with Giuseppe Caruso

Voices
Nevine Makram Labib

Nevine Makram Labib: Strategic Governance at the Intersection of AI and Oncology - ISCO 2026

Liang Cheng: Why UTUC Requires a Genomic Identity Distinct from Bladder Cancer

Matteo Lambertini: Continuing Great Collaboration in the Field of Breast Cancer at GBCC 2026

Raffaele Colombo: Strong Science, Meaningful Connections, and a Clear Goal of Making an Impact for Patients at AACR 2026

Douglas Flora: Join Haymarket Media Panel at ASCO on AI's Role in Patient-Provider Dialogue

Richard Paxman: An Evening Celebrating Advocacy and Support for Metastatic Breast Cancer Patients

Debra Montague: A Week of Progress Collaboration and Community at Lung Cancer Europe Conference in Vienna

FDA Approvals
Tecartus

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

NCCN 2026 Policy Summit: Innovations in Cancer Care Through the Ages

The National Comprehensive Cancer Network

25 Jun
NCCN

NCCN 2026 Policy Summit: Health Literacy in the Cancer Care Digital Age

The National Comprehensive Cancer Network

07 May
NCCN

NCCN Webinar Series - Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia

The National Comprehensive Cancer Network

06 May
Chronic Lymphocytic Leukemia

NCCN Global Policy Webinar - The Growing Cancer Burden in Young Adults

NCCN

21 May
NCCN

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

OncoDaily

30 Apr
Head and Neck Cancers

Immune-oncology
Top Immunotherapy Trials to Watch at ASCO 2026

Top Immunotherapy Trials to Watch at ASCO 2026

10 Must-Read Posts in Immuno-Oncology This Week

FDA Priority Review: Pembrolizumab + Enfortumab Vedotin for Cisplatin-Eligible MIBC

innovaTV Trial Update: Tisotumab Vedotin in Cervical Cancer

Spatial Omics for Characterizing the Dynamic Tumor Microenvironment

Beyond the Guideline: What Uveal Melanoma Experts Say Still Needs Attention

10 Must-Read Posts in Immuno-Oncology This Week

Gastrointestinal-Oncology
BBOpCo at AACR 2026

BBOpCo at AACR 2026: First-Line BOT/BAL in Selected MSS Colorectal Cancer Population

Promising Phase I Results for BOT/BAL and agenT-797 in PD-1 Refractory Gastroesophageal Cancer

10 Must-Read Posts In GI Oncology This Week

Phase II LEAP-005 Results: Lenvatinib plus Pembrolizumab in Pretreated GI Cancers

ESMO 2026 Guideline: Redefining the Management of Metastatic Colorectal Cancer

Immunotherapy in GI Cancers 2026: From Expansion to Precision

Phase 3 RASolute 302 Trial: Daraxonrasib Improves Overall Survival in Metastatic Pancreatic Cancer

Breast-Oncology
Breast Cancer

Top 10 Breast Cancer Abstracts To Watch At ESMO Breast Cancer 2026

PIK3CA Testing in Advanced HR+/HER2- Breast Cancer: New Expert Consensus Defines a Practical Path Forward

PREDICT sTILs: Bringing Immune Biology Into Chemotherapy Decisions for TNBC

Breast Cancer This Week: 10 Updates You Should Not Miss In April 13 to 20, 2026

GeparNuevo Long-Term Analysis: Durvalumab Improves Survival in Early Triple-Negative Breast Cancer

SONIA Trial Challenges Routine First-Line CDK4/6 Use in Advanced Breast Cancer

Single-Cell Spatial Atlas of the Aging Breast: How Normal Tissue Changes May Shape Breast Cancer Risk

Lung-Oncology
Ifinatamab Deruxtecan

Ifinatamab Deruxtecan Receives FDA Priority Review In Previously Treated ES-SCLC

LAT Plus EGFR TKIs In Advanced EGFR+ NSCLC: A New Multimodality Signal

Tumor-Draining Lymph Nodes in NSCLC: The Underused Frontier in Biomarker Discovery and Therapeutic Innovation

MATISSE Trial Suggests CD39 Blockade May Deepen Pathologic Response in Resectable NSCLC

ASCO 2026 Lung Cancer Preview: Key Trials With Practice-Changing Potential

CheckMate 77T Biomarker Analysis Highlights ctDNA and Genomic Signals of Benefit With Perioperative Nivolumab in Resectable NSCLC

Zoldonrasib Shows Early Strength in Previously Treated KRAS G12D NSCLC

OncoDaily TV
Giuseppe Caruso SGO 2026 Congress Highlights

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology – Key Takeaways with Giuseppe Caruso

RichardGoldberg

Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer

A new partnership to take cancer vaccines from research to care - with Karen Knudsen and Kristen Dahlgren

A new partnership to take cancer vaccines from research to care – with Karen Knudsen and Kristen Dahlgren

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Noetic Medicine: The Science Behind Healing Through Words

Noetic Medicine: The Science Behind Healing Through Words

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy - Episode 1

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy – Episode 1

ACT for Children Initiative: Making a Durable Change

ACT for Children Initiative: Making a Durable Change

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Ensuring equitable access to cancer care worldwide

Ensuring equitable access to cancer care worldwide: Pat Garcia-Gonzalez

How to Publish High-Impact Research in Top Journals

How to Publish High-Impact Research in Top Journals: Gustavo Monnerat

Empowering Oncologists

Empowering Oncologists: How Social Media Can Lead To Professional Collabortions And Advancement?

Not To Miss
Giuseppe Caruso SGO 2026 Congress Highlights

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology - Key Takeaways with Giuseppe Caruso

20 Posts Not To Miss From Lung Cancer Europe 2026 Conference

Recognition of Gratitude - ISCO 2026 Congress

Highlights From Myelo 2026: Virtual Global Myeloma Congress

Introducing the Chairs at ISCO Congress 2026 - Part 2

Introducing the Chairs at ISCO Congress 2026 - Part 1

Highlights from AACR 2026 Part 3

OncoGrants
Brain Tumour Foundation of Canada — 2026 Brain Tumour Research Feature Grant

Brain Tumour Foundation of Canada — 2026 Brain Tumour Research Feature Grant

ChadTough Defeat DIPG Foundation — Fellowship Grant

ChadTough Defeat DIPG Foundation — Fellowship Grant

Harvard Cancer Center Neuro-Oncology SPORE — Developmental Research Project Award

Harvard Cancer Center Neuro-Oncology SPORE — Developmental Research Project Award

Harvard Cancer Center Neuro-Oncology SPORE — Career Enhancement Program Award

Harvard Cancer Center Neuro-Oncology SPORE — Career Enhancement Program Award

NCI Glioblastoma Therapeutics Network RFA

NCI Glioblastoma Therapeutics Network RFA

Lustgarten Foundation — Robert F. Vizza Clinical Accelerator Initiative

Lustgarten Foundation — Robert F. Vizza Clinical Accelerator Initiative

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
AML

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

CancerWorld

Oncologists
Capucine Baldini

Capucine Baldini

Oncologists Location Villejuif, France
Wang Xishan

Wang Xishan

Oncologists Location Beijing, China
Rawad Rihani

Rawad Rihani

Oncologists Location Amman, Jordan
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Douglas Flora

Douglas Flora

Oncologists Location Edgewood, USA
Daniel Olson

Daniel Olson

Oncologists Location Chicago, USA
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria
Juliet Lumati

Juliet Lumati

Oncologists Location Illinois, USA

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

ROSELLA Trial

The ROSELLA trial: Relacorilant + Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer

Bi-Specific T cell

Bi-Specific T Cell Engagers in Cancer Therapy: Mechanisms, Advances, and Clinical Impact

KRAS G12V

KRAS G12V–Mutated NSCLC: Smoking-Driven Biology and Immunotherapy Sensitivity

KEYNOTE-158

KEYNOTE-158 Trial: Pembrolizumab Monotherapy in MSI-H/dMMR Recurrent Gliomas:

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts